Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
7.32
-0.14 (-1.88%)
At close: Aug 17, 2026, 4:00 PM EDT
7.30
-0.02 (-0.27%)
After-hours: Aug 17, 2026, 6:14 PM EDT
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $263.94 million as of August 17, 2026. Its market cap has increased by 40.87% in one year.
Market Cap
263.94M
Enterprise Value
89.48M
1-Year Change
40.87%
Ranking
Category
Stock Price
$7.32
ChartMarket Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $263.94M, an increase of 5.15%. That is a compound annual growth rate of 1.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 263.94M | -28.41% |
| Dec 31, 2025 | 368.66M | -39.78% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cartesian Therapeutics | 279.71M |
| ProQR Therapeutics | 278.01M |
| Bicycle Therapeutics | 276.47M |
| Lineage Cell Therapeutics | 274.40M |
| Sol-Gel Technologies | 273.68M |
| ALX Oncology Holdings | 272.41M |
| MacroGenics | 263.72M |
| Whitehawk Therapeutics | 263.67M |